Abstract
Amiodarone, a widely used iodine-containing antiarrhythmic drug, has been shown to divert the peripheral metabolism of T4 towards rT3 than T3. In this prospective study we correlated the concentration of the peripheral thyroid hormones in serum with that of amiodarone. Fifteen euthyroid volunteers were studied, 5 men and 10 women, with a mean age of 64.2 yr, who suffered from various cardiac arrhythmias (atrial fibrillation or multiple ventricular extrasystoles). Serum amiodarone, T4, T3, rT3 and TSH were determined before and 3, 7, and 14 days after the administration of 400–600 mg amiodarone/day. There was a small increase in serum T4 and a suggestive decrease in serum T3. The increase in serum rT3 was significant, with p < 0.05 for 3 days, p < 0.01 for 7 days and p < 0.005 for 14 days. There was a significant correlation between the level of serum amiodarone and the rise in serum rT3 (r = 0.385, p < 0.05). The rise in rT3 is the main thyroid abnormality after amiodarone administration and may be used as a rough index of the serum concentration of this drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosenbaum M.B., Chiale P.A., Halpen M.S. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am. J. Cardiol. 38: 934, 1976.
Heger J.J., Prystowsky E.N., Jackman W.M., Naccarelli G.V., Warfel K.A., Rinkenberger R.L., Zipes D.P. Amiodarone: clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N. Engl. J. Med. 305: 539, 1981.
Koutras D.A, Malamitsi J., Souvatzoglou A., Piperingos G.D., Livadas D.P., Boukis M., Papachristou D.N., Sfontouris J., Moulopoulos S.D. Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent. J. Endocrinol. Invest. 4: 343, 1981.
Kitsopanides J., Koutras D.A, Souvatzoglou A., Boukis M., Piperingos G.D., Sfontouris J., Moulopoulos S.D. Metabolic insufficiency as a limiting factor in the dietetic treatment of obesity. Horm. Metab. Res. 73: 477, 1981.
Nana-Anastasiou M., Levis G.M., and Moulopoulos S. Pharmacokinetics of amiodarone following oral and intravenous administration. Int. J. Clin. Pharmacol. Biopharm. 20: 524, 1982.
Pritchard D.A., Singh B.N., Hurley P.J. Effects of amiodarone on thyroid function in patients with ische.mic heart disease. Br. Heart J. 37: 856, 1975.
Burger A., Dinichert C., Nicod P., Jenny M., Lemarchand-Beraud P., Valloton M.B. Effects of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J. Clin. Invest. 58: 255, 1976.
Jonckheer M.H., Blockx P., Boreckaert I., Cornette C., Beckers C. Low T3 syndrome in patients chronically treated with an iodine-containing drug, amiodarone. Clin. Endocrinol. 9: 27, 1978.
Melmed S., Nademanee K., Reed A.W., Hendrickson J.A., Singh B.N., Hershman J.M. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion following chronic amiodarone administration. J. Clin. Endocrinol. Metab. 53: 997, 1981.
Nademanee K., Singh B.N., Phil D., Hendrickson J.A., Reed A.W., Melmed S., Hershman J. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation 66: 202, 1982.
Lambert M.J., Burger A.G., Galeazzi R.L., Engler D. Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism? J. Clin. Endocrinol. Metab. 55: 1058, 1982.
Sogol P.B., Reed A.W., Melmed S., Pekary E.A., Hershman J.M. Amiodarone increases serum thyroid hormones and decreases hepatic 3′-monodeiodination in rats. Amer. Thyr. Assoc, 57th meeting, Minneapolis, Minnesota, Sept. 17–19, 1981 (Abstract).
Apostolou T. Effects of potassium iodide alone or combined with bronchodilating drugs on thyroid function. Thesis -Athens, 1981.
Goldfine I.D., Maddux B., Woeber K.A. Effect of amiodarone on L-triiodothyronine stimulation of (3H) thymidine incorporation into GH3 cells. J. Endocrinol. Invest. 5: 165, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anastasiou-Nana, M., Koutras, D.A., Levis, G. et al. The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine. J Endocrinol Invest 7, 405–407 (1984). https://doi.org/10.1007/BF03351026
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351026